Oncología Traslacional
ONCTRAS
Sarah Cannon Research Institute
Nashville, Estados UnidosPublicaciones en colaboración con investigadores/as de Sarah Cannon Research Institute (3)
2020
-
Phase Ib study of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients with platinum-resistant ovarian cancer
Gynecologic Oncology, Vol. 157, Núm. 2, pp. 379-385
2018
2013
-
Safety and efficacy of everolimus with exemestane vs. Exemestane alone in elderly patients with HER2-negative, hormone receptor-positive breast cancer in BOLERO-2
Clinical Breast Cancer, Vol. 13, Núm. 6, pp. 421-432.e8